Female Sexual Dysfunction: Lead Agents Are New Formulations Of Marketed Drugs

Procter & Gamble will likely have the first product to treat hypoactive sexual desire disorder in women with its Phase III testosterone patch Intrinsa. Vivus has late-stage compounds for two major components of female sexual dysfunction: a testosterone spray for hypoactive desire and a topical alprostadil for female sexual arousal disorder.